Pfizer Limited — Board Meeting, 28-10-2024: Outcome of Board Meeting

Pursuant to the Regulation 33 of the Listing Regulations, we submit herewith the UnauditedFinancial Results for the quarter and half year ended September 30, 2024, which were approvedby the Board of Directors of the Company at their Meeting held today, that commenced at3.00 p.m. and concluded at 5.45 p.m.Also please find enclosed the Limited Review Report issued by the Statutory Auditors namely,B. S. R. & Co., LLP, in respect of the said Unaudited Financial Results.